Vaccine nanoparticles (IMAGE)
Caption
Three of the six vaccine nanoparticles used in the study, engineered to display different numbers of functional B cell binding sites: none (left), about half (center), or all (right). The particles show the HIV antigen in blue, its glycan shield in green, the protein core in grey, and inactive binding sites in pink.
Credit
Scripps Research
Usage Restrictions
Can be used with related coverage and with credit
License
Original content